Transplant News and Research

RSS
IDIBELL licenses a tool to Oxford Immunotec to improve efficiency of kidney transplants, prevent graft rejection

IDIBELL licenses a tool to Oxford Immunotec to improve efficiency of kidney transplants, prevent graft rejection

UChicago Medicine contributes to Illinois Transplant Fund

UChicago Medicine contributes to Illinois Transplant Fund

IU scientists find evidence that invisible war between microorganisms may affect human health

IU scientists find evidence that invisible war between microorganisms may affect human health

Finding by UCSF researchers could increase availability of kidneys for transplant

Finding by UCSF researchers could increase availability of kidneys for transplant

Researchers demonstrate direct connection between NOX proteins and liver fibrosis

Researchers demonstrate direct connection between NOX proteins and liver fibrosis

New computer-based system provides real-time feedback before and during facial transplant surgery

New computer-based system provides real-time feedback before and during facial transplant surgery

CHOP surgeons successfully complete world's first bilateral hand transplant on child

CHOP surgeons successfully complete world's first bilateral hand transplant on child

Organ donor honored at Reagan UCLA Medical Center

Organ donor honored at Reagan UCLA Medical Center

NEJM suggests use of HCV-positive kidneys as one solution to kidney shortage

NEJM suggests use of HCV-positive kidneys as one solution to kidney shortage

Stem cell transplantation improves outcomes in children with rare form of chronic blood cancer

Stem cell transplantation improves outcomes in children with rare form of chronic blood cancer

NeoGraft selects Verasoni Worldwide as marketing communications partner

NeoGraft selects Verasoni Worldwide as marketing communications partner

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Omeros' OMS721 granted FDA Fast Track designation for treatment of atypical hemolytic uremic syndrome

Omeros' OMS721 granted FDA Fast Track designation for treatment of atypical hemolytic uremic syndrome

UC San Diego researchers identify pivotal player in diabetic kidney disease

UC San Diego researchers identify pivotal player in diabetic kidney disease

UT Southwestern named one of 'Most Wired' hospitals in nation for fifth consecutive year

UT Southwestern named one of 'Most Wired' hospitals in nation for fifth consecutive year

Dietary phosphate appears to cause spikes in blood phosphorus levels

Dietary phosphate appears to cause spikes in blood phosphorus levels

Adaptimmune’s NY-ESO-1 TCR-engineered T-cell therapy mediates sustained antitumor effects in multiple myeloma patients

Adaptimmune’s NY-ESO-1 TCR-engineered T-cell therapy mediates sustained antitumor effects in multiple myeloma patients

Researchers use iPSCs to explore new treatments for kidney disease

Researchers use iPSCs to explore new treatments for kidney disease

Patients' own genetically engineered immune cells show significant success against multiple myeloma

Patients' own genetically engineered immune cells show significant success against multiple myeloma

New drug cures malaria in mice

New drug cures malaria in mice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.